Assisted reproduction provides bright future for HIV positive men - butseems less successful for womenMay 24, 2003Assisted reproduction can safely help HIV positive men to become fathers without infecting their partners, according to new research from French fertility experts. But, the news is not so good for HIV positive women. Assisted reproduction techniques do not seem to provide the same success for them, the researchers reported today (Thursday 29 May) in Europe's leading reproductive medicine journal Human Reproduction[1]. Dr Jeanine Ohl and her Strasbourg-based team carried out various assisted reproduction techniques on 57 couples in which at least one partner was HIV positive. For the HIV positive men with HIV negative partners they 'washed' the sperm using two successive techniques that involved separating the motile sperm from the semen and using the sperm that tested negative for insemination. Nearly a third of the 39 couples where the male was infected became parents with the birth of 14 children to 12 couples. None of the women became infected. Of the three assisted reproductive techniques used - intrauterine insemination (IUI), IVF or ICSI (injection of the egg with a single sperm), ICSI was the most successful, resulting in pregnancies in nearly a half of all the embryos transferred. No pregnancies were achieved using IUI. However, of the 10 HIV positive women treated, only one became pregnant. Thirty-seven couples are still being treated. Dr Ohl, a specialist in assisted reproduction techniques for serodiscordant couples, at Centre d'AMP de Strasbourg, said: "I was very pleased by the good results for men, but surprised at the poor results for women, which I did not expect. One explanation may be that the men did not have any fertility problems but the women did. The women were significantly older than the partners of the seropositive men and some had waited a long time for this treatment, which only became possible because of changes in the law in France two years ago[2]." Dr Ohl said her team was now planning an observational study of ovarian function in HIV positive women. "Some research has found evidence of premature ovarian failure in infected women although this would need confirming in a larger study. On the other hand, in developing countries young infected women become pregnant easily. We have to determine whether the virus has created an additional negative factor. Perhaps 'at home' inseminations could be advised if a couple is very young." She said the ART programme for serodiscordant couples was extremely rewarding for the research team and provided hope for the future for people infected by HIV. More than half the people infected by HIV were of childbearing age. Progress in treatment had substantially modified the outlook for patients. The infection often did not progress and could be considered to be chronic. "Patients can thus make life plans and even envisage having children. This pressing desire for children is legitimate and any other conclusion would discriminate against these patients. A cultural revolution is taking place, especially in the medical profession," she said. (ends) [1]Assisted reproduction techniques for HIV serodiscordant couples: 18 months of experience. Human Reproduction. Vol. 18. No 6. Pp 1244-1249. [2]A decree about assisted reproductive treatment of patients with viral risks (Journal Officiel de la République Fran'§aise May 15 2001) extended permission to treat serodiscordant couples in which the woman is infected. Rules on treating HIV patients are different in different countries. Several countries accept treatment for HIV positive men but few accept infected women. MW Communications |
|||||||||||||||||||||
| Related HIV Current Events and HIV News Articles Many pregnant women avoid HIV screening in Africa 'Prevention is the best cure' is a common expression, but what happens if preventative measures are not used? A large proportion of pregnant Ugandan women are going out of their way not to be HIV tested, increasing the risk of mother-to-child transmission. An atomic-level look at an HIV accomplice Since the discovery in 2007 that a component of human semen called SEVI boosts infectivity of the virus that causes AIDS, researchers have been trying to learn more about SEVI and how it works, in hopes of thwarting its infection-promoting activity. New findings suggest strategy to help generate HIV-neutralizing antibodies New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease. No-entry zones for AIDS virus The AIDS virus inserts its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center have now shown for the first time that the virus almost entirely spares particular sites in the human genetic material in this process. This finding may be useful for developing new, specific AIDS drugs. Hoping for a fluorescent basket case Although recent advances have raised hopes that a protective vaccine can be developed, acquired immunodeficiency syndrome (AIDS) remains a major public health problem. Scientists explain binding action of 2 key HIV antibodies; could lead to new vaccine design A very close and detailed study of how the most robust antibodies work to block the HIV virus as it seeks entry into healthy cells has revealed a new direction for researchers hoping to design an effective vaccine. U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide. 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. Indiana U. at APHA: Studies about why men and women use lubricants during sex An Indiana University study involving 2,453 women ages 18 to 68 found that lubricant use during sexual activity alone or with a partner contributed to higher ratings of pleasurable and satisfying sex. More HIV Current Events and HIV News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||